The metabolic syndrome increased risk of cardiovascular events in Chinese-A community based study

International Journal of Cardiology

Volumn 139, Issue 2, 2010, Pages 159-165

  Wang, Chen ^a   Hou, Xuhong ^a   Bao, Yuqian ^a   Pan, Jiemin ^a   Zuo, Yuhua ^b   Zhong, Wenhong ^c   Jia, Weiping ^a   Xiang, Kunsan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b Caoyang Health Center   (China)

^c Huayang Health Center   (China)

Author keywords

Cardiovascular disease; Hazard ratio; Metabolic syndrome

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINESE; COHORT ANALYSIS; FEMALE; HAZARD RATIO; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; WORLD HEALTH ORGANIZATION;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHINA; CHOLESTEROL, HDL; DYSLIPIDEMIAS; FEMALE; HUMANS; INCIDENCE; INSULIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; TRIGLYCERIDES;

EID: 77249178332     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.10.012     Document Type: Article

References (33)

1. Garber A.J. The metabolic syndrome. Med Clin North Am 88 (2004) 837-846
2. Gu D., Reynolds K., Wu X., et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365 (2005) 1398-1405
3. James P.T., Rigby N., and Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 11 (2004) 3-8
4. Zimmet P.Z., McCarty D.J., and de Courten M.P. The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. J Diabetes Its Complicat 11 (1997) 60-68
5. Dekker J.M., Girman C., Rhodes T., et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 112 (2005) 666-673
6. Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28 (2005) 1769-1778
7. Hunt K.J., Resendez R.G., Williams K., Haffner S.M., and Stern M.P. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110 (2004) 1251-1257
8. Qiao Q. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 49 (2006) 2837-2846
9. Sone H., Mizuno S., Fujii H., et al. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients? Analysis from the Japan Diabetes Complications Study. Diabetes Care 28 (2005) 1463-1471
10. Thomas G.N., Schooling C.M., McGhee S.M., et al. Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study. Clin Endocrinol (Oxf) 66 (2007) 666-671
11. Bao Y., Lu J., Wang C., et al. Optimal waist circumference cutoffs for abdominal obesity in Chinese. Atherosclerosis 201 (2008) 378-384
12. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and Classification of Diabetes Mellitus (1999), World Health Organization, Geneva
13. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
15. Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. [Chinese guidelines on prevention and treatment of dyslipidemia in adults]. Zhonghua Xin Xue Guan Bing Za Zhi 35 (2007) 390-419
16. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
17. Giugliano D., and Esposito K. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes: response to Kahn et al. Diabetes Care 29 (2006) 175-176
18. Grundy S.M. Does the metabolic syndrome exist?. Diabetes Care 29 (2006) 1689-1692
19. Ko G.T. Metabolic syndrome or "central obesity syndrome"?. Diabetes Care 29 (2006) 752-752
20. Jia W.P., Pang C., Chen L., et al. Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 50 (2007) 286-292
21. Jia W., Wu H., Bao Y., et al. Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab 92 (2007) 3224-3229
22. Wu Y.F., Zhao D., Zhou B.F., et al. [Cut offs and risk stratification of dyslipidemia in Chinese adults]. Zhonghua Xin Xue Guan Bing Za Zhi 35 (2007) 428-433
23. Gaziano T.A., Opie L.H., and Weinstein M.C. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 368 (2006) 679-686
24. Liu L. Cardiovascular diseases in China. Biochem Cell Biol 85 (2007) 157-163
25. Bejot Y., Benatru I., Rouaud O., et al. Epidemiology of stroke in Europe: geographic and environmental differences. J Neurol Sci 262 (2007) 85-88
26. Forouhi N.G., and Sattar N. CVD risk factors and ethnicity-a homogeneous relationship?. Atheroscler Suppl 7 (2006) 11-19
27. Wu Z., Yao C., Zhao D., et al. Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, part I: morbidity and mortality monitoring. Circulation 103 (2001) 462-468
28. Zhao L., Stamler J., Yan L.L., et al. Blood pressure differences between northern and southern Chinese: role of dietary factors: the International Study on Macronutrients and Blood Pressure. Hypertension 43 (2004) 1332-1337
29. Wang Z., Wu Y., Zhao L., Li Y., Yang J., and Zhou B. Trends in prevalence, awareness, treatment and control of hypertension in the middle-aged population of China, 1992-1998. Hypertens Res 27 (2004) 703-709
30. Chen H.J., Bai C.H., Yeh W.T., Chiu H.C., and Pan W.H. Influence of metabolic syndrome and general obesity on the risk of ischemic stroke. Stroke 37 (2006) 1060-1064
31. Jeppesen J., Hansen T.W., Rasmussen S., Ibsen H., and Torp-Pedersen C. Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease: a population-based study. Atherosclerosis 189 (2006) 369-374
32. Nilsson P.M., Engstrom G., and Hedblad B. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects-a population-based study comparing three different definitions. Diabet Med 24 (2007) 464-472
33. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150